Literature DB >> 23370181

Peru's national folic acid fortification program and its effect on neural tube defects in Lima.

Daniel J Ricks1, Chris A Rees, Katharine A Osborn, Benjamin T Crookston, Katherine Leaver, Samuel B Merrill, Carlos Velásquez, Jane H Ricks.   

Abstract

OBJECTIVE: To evaluate the impact of Peru's national folic acid fortification program on folic acid content in wheat flour, and the effect on birth prevalence of neural tube defects (NTDs) in Lima, and to compare the program's legislative requirements with international standards.
METHODS: Bread was sampled from six sites across Peru and tested for folic acid. Data were obtained from the largest obstetric hospital in Lima on the prevalence of births (live and still) with NTDs during both the pre-fortification period (2004-2005) and post-fortification years (2007-2008).
RESULTS: Folic acid content in the sampled bread met national legislative requirements but was less than one-half of the level recommended for Peru by the World Health Organization (WHO) (2.6 mg/kg wheat flour). Birth prevalence of NTDs was 18.4/10 000 in the pre-fortification period and 20.0/10 000 during post-fortification years. Relative risk for NTDs after fortification was 1.02 (95% confidence interval 0.77-1.35, P = 0.90).
CONCLUSIONS: Peruvian legislative requirements for folic acid fortification are below international (WHO) recommendations; birth prevalence of NTDs in Lima is higher than international benchmarks; and no decrease in NTDs following fortification of flour with folic acid (according to Peruvian national standards) was observed. As increasing the level of folic acid in flour remains the most sustainable way of preventing NTDs, it is recommended that Peru increase its folic acid fortification requirements to meet those recommended by WHO (2.6 mg/kg).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23370181

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  7 in total

1.  Hair Mercury Level is Associated with Anemia and Micronutrient Status in Children Living Near Artisanal and Small-Scale Gold Mining in the Peruvian Amazon.

Authors:  Caren Weinhouse; Ernesto J Ortiz; Axel J Berky; Paige Bullins; John Hare-Grogg; Laura Rogers; Ana-Maria Morales; Heileen Hsu-Kim; William K Pan
Journal:  Am J Trop Med Hyg       Date:  2017-09-21       Impact factor: 2.345

2.  Improved micronutrient status and health outcomes in low- and middle-income countries following large-scale fortification: evidence from a systematic review and meta-analysis.

Authors:  Emily C Keats; Lynnette M Neufeld; Greg S Garrett; Mduduzi N N Mbuya; Zulfiqar A Bhutta
Journal:  Am J Clin Nutr       Date:  2019-06-01       Impact factor: 7.045

3.  A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels.

Authors:  Meinrad Lindschinger; Franz Tatzber; Wolfgang Schimetta; Irene Schmid; Barbara Lindschinger; Gerhard Cvirn; Olaf Stanger; Eugenia Lamont; Willibald Wonisch
Journal:  Oxid Med Cell Longev       Date:  2019-12-12       Impact factor: 6.543

Review 4.  Spina bifida.

Authors:  Andrew J Copp; N Scott Adzick; Lyn S Chitty; Jack M Fletcher; Grayson N Holmbeck; Gary M Shaw
Journal:  Nat Rev Dis Primers       Date:  2015-04-30       Impact factor: 52.329

5.  Nucleotide precursors prevent folic acid-resistant neural tube defects in the mouse.

Authors:  Kit-Yi Leung; Sandra C P De Castro; Dawn Savery; Andrew J Copp; Nicholas D E Greene
Journal:  Brain       Date:  2013-08-08       Impact factor: 13.501

6.  Estimating the burden of neural tube defects in low- and middle-income countries.

Authors:  Annie Lo; Dora Polšek; Simrita Sidhu
Journal:  J Glob Health       Date:  2014-06       Impact factor: 4.413

7.  Parents' perceived knowledge and beliefs on congenital malformations and their causes in the Amhara region, Ethiopia. A qualitative study.

Authors:  Molla Taye
Journal:  PLoS One       Date:  2021-11-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.